---
figid: PMC4393483__sfs07901
figtitle: Biochemical pathway of the disease
organisms:
- Homo sapiens
pmcid: PMC4393483
filename: sfs07901.jpg
figlink: /pmc/articles/PMC4393483/figure/SFS079F1/
number: F1
caption: Biochemical pathway of the disease. Deficiency of homogentisate 1,2-dioxygenase
  (HGO) in the tyrosine degradation pathway leads to alkaptonuria.
papertitle: Impact of chronic kidney disease on the natural history of alkaptonuria.
reftext: Bernardo Faria, et al. Clin Kidney J. 2012 Aug;5(4):352-355.
year: '2012'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8615019
figid_alias: PMC4393483__F1
figtype: Figure
organisms_ner:
- NA
redirect_from: /figures/PMC4393483__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4393483__sfs07901.html
  '@type': Dataset
  description: Biochemical pathway of the disease. Deficiency of homogentisate 1,2-dioxygenase
    (HGO) in the tyrosine degradation pathway leads to alkaptonuria.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - 4-Hydroxyphenylpyruvic acid
  - Succinylacetone
  - Phenylalanine
  - Tyrosine
---
